Cell Death and Disease Journal Citation Rate 2026

ISSN 2041-4889 Springer Nature GB

Q1 Quartile Open Access Top Tier

About Cell Death and Disease
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cell Death and Disease (CDD) is a peer-reviewed academic journal covering Autophagy in Disease and Therapy and Cancer-related molecular mechanisms research, published by Springer Nature in GB, catalogued under ISSN 2041-4889. As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.50 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access. OpenAlex records 12,208 works and 601,627 citations, with an h-index of 237.

Authors typically receive a first decision in around 67 days.

Cell Death and Disease Citation Rate 2026 — In Context

Cell Death and Disease has a 2024 2-Year Citation Rate (OpenAlex) of 64.50, placing it in the Q1 quartile within the Autophagy in Disease and Therapy research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Cell Death and Disease makes all articles freely available to readers. Average submission-to-decision turnaround is approximately 67 days.

Researchers looking to publish in Cell Death and Disease should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cell Death and Disease against similar journals in the field, use our journal comparison tool.

Submission Tips for Cell Death and Disease
  • Be prepared for a longer review cycle — decisions typically take around 67 days.
  • This journal covers Autophagy in Disease and Therapy, Cancer-related molecular mechanisms research, Epigenetics and DNA Methylation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cell Death and … Compares
Citation Rate vs Field Avg
+301%
Field avg: 16.07

Compared against 59 journals in the same research areas.

ISSN (Print) 2041-4889
Publisher Springer Nature
Country United Kingdom
APC / Cost Inquire with Publisher
Review Speed ~67 days to first decision
In-depth profile & metrics

Cell Death and Disease is published by Springer Nature and based in United Kingdom. It publishes on an open-access basis.

In our subject taxonomy, Cell Death and Disease is classified under Autophagy in Disease and Therapy, Cancer-related molecular mechanisms research, Epigenetics and DNA Methylation and MicroRNA in disease regulation.

For prospective authors, Cell Death and Disease returns a first decision in about 67 days (longer for its field).

Its citation rate has held broadly steady over the last 1 years, from 61.275 (2023) to 64.500 (2024).

Research Areas
Links
Frequently Asked Questions about Cell Death and Disease

Cell Death and Disease does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 64.500 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Cell Death and Disease is an open access journal.

The average time from submission to first decision at Cell Death and Disease is approximately 67 days.

Cell Death and Disease is published by Springer Nature.

Cell Death and Disease shows strong legitimacy signals: it is indexed in DOAJ. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cell Death and Disease is 2041-4889.

Cell Death and Disease sits in the Q1 quartile based on its latest impact factor of 64.50, ranked across all journals in our database.
Live Indexing Status
Updated March 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
64.500
2-Year Citation Rate (OpenAlex) · 2024
Historical Trend

The impact factor has remained stable over the last 1 years (from 61.275 to 64.500), reflecting consistent citation performance.

Citation Rate by Year
Year Value Source
2024 64.500 2-Year Mean Citedness (OpenAlex)
2023 61.275 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Journal Metrics
67
Days to Decision
Research Highlights

Recently published high-impact papers in this journal:

Compare Journals

Compare Cell Death and Disease against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Mar 20, 2026

Updated by: system

Get weekly updates for Autophagy in Disease and Therapy journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google